4.7 Article

Rhodanese, but not cystathionine-γ-lyase, is associated with dextran sulfate sodium-evoked colitis in mice: A sign of impaired colonic sulfide detoxification?

Journal

TOXICOLOGY
Volume 264, Issue 1-2, Pages 96-103

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.tox.2009.07.018

Keywords

Hydrogen sulfide; Ulcerative colitis; Cystathionine-gamma-lyase; Rhodanese; Dextran sulfate sodium

Funding

  1. Ministry of Education, Culture, Sports, Science and Technology

Ask authors/readers for more resources

Clinical studies suggest that colonic luminal hydrogen sulfide (H2S), produced by sulfate-reducing bacteria or through other pathways, might be involved in the pathogenesis of inflammatory bowel disease (IBD). Nonetheless, this hypothesis has been poorly investigated by basic studies using laboratory animals. We thus focused on two enzymes, cystathionine-gamma-lyase (CSE) that generates H2S from L-cysteine, and rhodanese that directly or indirectly detoxifies H2S, particularly in relation to the colitis induced by dextran sulfate sodium (DSS) in mice. CSE was a major H2S-forming enzyme in colonic and renal homogenates from mice and rats, and the rhodanese activity was also detectable in both tissues. Colitis-related symptoms including decreased body weight gain, diarrhea, hematochezia and shortening of colon length were observed in the mice drinking DSS. Those symptoms were not or only slightly attenuated by repeated administration of a CSE inhibitor. CSE activity and protein levels in the colonic tissue did not notably change in the mice with colitis. In contrast, the activity and protein/mRNA levels of rhodanese in the colon, but not kidney, significantly decreased nearly in parallel with the development of colitis, followed by elevation of rhodanese activity in red blood cells (RBCs). These data show that rhodanese, but not CSE, is associated with DSS-induced colitis in mice, leading to a hypothesis that impaired detoxification of H2S due to down-regulation or suppression of colonic rhodanese is involved in IBD. The delayed enhancement of rhodanese activity in RBCs, a possible compensative event, might be available as a disease marker for IBD. (C) 2009 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Neurosciences

Role of Thrombin in Soluble Thrombomodulin-Induced Suppression of Peripheral HMGB1-Mediated Allodynia in Mice

Ryuichi Tsujita, Maho Tsubota, Yusuke Hayashi, Haruka Saeki, Fumiko Sekiguchi, Atsufumi Kawabata

JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2018)

Review Pharmacology & Pharmacy

Involvement of Voltage-Gated Calcium Channels in Inflammation and Inflammatory Pain

Fumiko Sekiguchi, Maho Tsubota, Atsufumi Kawabata

BIOLOGICAL & PHARMACEUTICAL BULLETIN (2018)

Article Neurosciences

Paclitaxel-induced HMGB1 release from macrophages and its implication for peripheral neuropathy in mice: Evidence for a neuroimmune crosstalk

Fumiko Sekiguchi, Risa Domoto, Kana Nakashima, Daichi Yamasoba, Hiroki Yamanishi, Maho Tsubota, Hidenori Wake, Masahiro Nishibori, Atsufumi Kawabata

NEUROPHARMACOLOGY (2018)

Article Health Care Sciences & Services

The C-Reactive Protein/Albumin Ratio Is Useful for Predicting Short-Term Survival in Cancer and Noncancer Patients

Tomoyoshi Miyamoto, Masanori Fujitani, Hiroki Fukuyama, Shigekatsu Hatanaka, Yuichi Koizumi, Atsufumi Kawabata

JOURNAL OF PALLIATIVE MEDICINE (2019)

Article Pharmacology & Pharmacy

NNC 55-0396, a T-type calcium channel blocker, protects against the brain injury induced by middle cerebral artery occlusion and reperfusion in mice

Sachi Matsuda, Hiroyuki Nishikawa, Anna Fukatsu, Yuko Kurokawa, Maho Tsubota, Fumiko Sekiguchi, Shogo Tokuyama, Atsufumi Kawabata

JOURNAL OF PHARMACOLOGICAL SCIENCES (2019)

Article Pharmacology & Pharmacy

Critical role of Cav3.2 T-type calcium channels in the peripheral neuropathy induced by bortezomib, a proteasome-inhibiting chemotherapeutic agent, in mice

Shiori Tomita, Fumiko Sekiguchi, Tomoyo Deguchi, Takaya Miyazaki, Yuya Ikeda, Maho Tsubota, Shigeru Yoshida, Huy Du Nguyen, Takuya Okada, Naoki Toyooka, Atsufumi Kawabata

TOXICOLOGY (2019)

Article Biochemistry & Molecular Biology

Dietary ascorbic acid restriction in GNL/SMP30-knockout mice unveils the role of ascorbic acid in regulation of somatic and visceral pain sensitivity

Maho Tsubota, Kenta Uebo, Koki Miki, Fumiko Sekiguchi, Akihiko Ishigami, Atsufumi Kawabata

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)

Article Pharmacology & Pharmacy

Genetic deletion of Cav3.2 T-type calcium channels abolishes H2S-dependent somatic and visceral pain signaling in C57BL/6 mice

Kazuki Matsui, Maho Tsubota, Saaya Fukushi, Nene Koike, Hiroshi Masuda, Yoshihito Kasanami, Takaya Miyazaki, Fumiko Sekiguchi, Tsuyako Ohkubo, Shigeru Yoshida, Yutaro Mukai, Akira Oita, Mitsutaka Takada, Atsufumi Kawabata

JOURNAL OF PHARMACOLOGICAL SCIENCES (2019)

Article Immunology

Role of non-macrophage cell-derived HMGB1 in oxaliplatin-induced peripheral neuropathy and its prevention by the thrombin/thrombomodulin system in rodents: negative impact of anticoagulants

Maho Tsubota, Ryotaro Fukuda, Yusuke Hayashi, Takaya Miyazaki, Shin Ueda, Rika Yamashita, Nene Koike, Fumiko Sekiguchi, Hidenori Wake, Shuji Wakatsuki, Yuka Ujiie, Toshiyuki Araki, Masahiro Nishibori, Atsufumi Kawabata

JOURNAL OF NEUROINFLAMMATION (2019)

Article Pharmacology & Pharmacy

Tacrolimus, a calcineurin inhibitor, promotes capsaicin-induced colonic pain in mice

Kazuki Matsui, Yuka Terada, Maho Tsubota, Fumiko Sekiguchi, Atsufumi Kawabata

JOURNAL OF PHARMACOLOGICAL SCIENCES (2020)

Article Pharmacology & Pharmacy

HMGB1 and its membrane receptors as therapeutic targets in an intravesical substance P-induced bladder pain syndrome mouse model

Yuhei Irie, Maho Tsubota, Mariko Maeda, Shiori Hiramoto, Fumiko Sekiguchi, Hiroyasu Ishikura, Hidenori Wake, Masahiro Nishibori, Atsufumi Kawabata

JOURNAL OF PHARMACOLOGICAL SCIENCES (2020)

Review Biochemistry & Molecular Biology

Role of HMGB1 in Chemotherapy-Induced Peripheral Neuropathy

Fumiko Sekiguchi, Atsufumi Kawabata

Summary: Chemotherapy-induced peripheral neuropathy (CIPN) is resistant to most existing medicines and is one of the major dose-limiting side effects of chemotherapeutic agents. HMGB1 plays a key role in the development of CIPN, while TMα is effective in preventing CIPN in both animal models and patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Cell Biology

Macrophage as a Peripheral Pain Regulator

Risa Domoto, Fumiko Sekiguchi, Maho Tsubota, Atsufumi Kawabata

Summary: Neuroimmune crosstalk plays a crucial role in both somatic and visceral pathological pain, with macrophages interacting with neurons to regulate pain signals in peripheral tissues; recent studies have uncovered different characteristics and mediators of macrophages from various sources, highlighting their multitasking abilities in homeostatic conditions.

CELLS (2021)

Article Cell Biology

Caspase-Dependent HMGB1 Release from Macrophages Participates in Peripheral Neuropathy Caused by Bortezomib, a Proteasome-Inhibiting Chemotherapeutic Agent, in Mice

Maho Tsubota, Takaya Miyazaki, Yuya Ikeda, Yusuke Hayashi, Yui Aokiba, Shiori Tomita, Fumiko Sekiguchi, Dengli Wang, Masahiro Nishibori, Atsufumi Kawabata

Summary: Bortezomib-induced chemotherapy-induced peripheral neuropathy (CIPN) involves caspase-dependent release of HMGB1 from macrophages, leading to the activation of RAGE and CXCR4 receptors. Preventative measures for CIPN include the use of anti-HMGB1-neutralizing antibodies, thrombomodulin alfa, RAGE and CXCR4 antagonists, or macrophage depletion.

CELLS (2021)

Article Pharmacology & Pharmacy

Involvement of NF-κB in the upregulation of cystathionine-γ-lyase, a hydrogen sulfide-forming enzyme, and bladder pain accompanying cystitis in mice

Tomoka Ozaki, Maho Tsubota, Fumiko Sekiguchi, Atsufumi Kawabata

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2018)

No Data Available